0001209191-19-047993.txt : 20190903 0001209191-19-047993.hdr.sgml : 20190903 20190903164918 ACCESSION NUMBER: 0001209191-19-047993 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190830 FILED AS OF DATE: 20190903 DATE AS OF CHANGE: 20190903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALSADA CRISPINA CENTRAL INDEX KEY: 0001606833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 191072532 MAIL ADDRESS: STREET 1: C/O AMBRX, INC. STREET 2: 10975 N. TORREY PINES RD. CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 225 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-30 0 0001505512 Regulus Therapeutics Inc. RGLS 0001606833 CALSADA CRISPINA C/O REGULUS THERAPEUTICS 10628 SCIENCE CENTER DR. #225 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 0.62 2019-08-30 4 A 0 100000 0.00 A 2029-08-29 Common Stock 100000 100000 D Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant. Christopher Aker, Attorney in Fact 2019-09-03